Strides Pharma Science Ltd
NSE:STAR

Watchlist Manager
Strides Pharma Science Ltd Logo
Strides Pharma Science Ltd
NSE:STAR
Watchlist
Price: 805 INR 1.1% Market Closed
Market Cap: ₹74.2B

Operating Margin

14.6%
Current
Improving
by 3.8%
vs 3-y average of 10.8%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
14.6%
=
Operating Income
₹6.8B
/
Revenue
₹46.8B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
14.6%
=
Operating Income
₹6.8B
/
Revenue
₹46.8B

Peer Comparison

Country Company Market Cap Operating
Margin
IN
Strides Pharma Science Ltd
NSE:STAR
73.8B INR
Loading...
US
Eli Lilly and Co
NYSE:LLY
972.2B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
547.5B USD
Loading...
CH
Roche Holding AG
SIX:ROG
277.1B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.4B GBP
Loading...
CH
Novartis AG
SIX:NOVN
219B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
272.1B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
148.3B USD
Loading...
FR
Sanofi SA
PAR:SAN
93.8B EUR
Loading...

Market Distribution

Higher than 73% of companies in India
Percentile
73rd
Based on 5 437 companies
73rd percentile
14.6%
Low
-153 833.3% — 2.7%
Typical Range
2.7% — 13.2%
High
13.2% — 9 977%
Distribution Statistics
India
Min -153 833.3%
30th Percentile 2.7%
Median 7.3%
70th Percentile 13.2%
Max 9 977%

Strides Pharma Science Ltd
Glance View

Strides Pharma Science Ltd. engages in the development, manufacture and distribution of Internet Protocol-led generics and bio-pharmaceutical products. The company is headquartered in Bangalore, Karnataka. The company went IPO on 2000-02-03. The firm is focused on development and manufacture of IP-led niche and pharmaceutical products. The company operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The firm manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as, liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. The company has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). The company is also engaged in manufacturing soft gelatin capsules. The company develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.

STAR Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
14.6%
=
Operating Income
₹6.8B
/
Revenue
₹46.8B
What is Strides Pharma Science Ltd's current Operating Margin?

The current Operating Margin for Strides Pharma Science Ltd is 14.6%, which is above its 3-year median of 10.8%.

How has Operating Margin changed over time?

Over the last 3 years, Strides Pharma Science Ltd’s Operating Margin has increased from -1.8% to 14.6%. During this period, it reached a low of -1.8% on Sep 30, 2022 and a high of 15.2% on Dec 31, 2024.

Back to Top